 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 81 - 90 of 2154:
AirStrip’s iPhone application Approved by FDA
FDA has given approval to AirStrip Technologies LP to market the company’s obstetrician application on Apple Inc.’s iPhone.San Antonio-based AirStrip ...
Akorn Announces FDA Approval of Akten Ophthalmic Gel 3.5%
Akorn, Inc. has announced the FDA approval of NDA 22-221 for Akten Ophthalmic Gel 3.5%, a topical, ocular anesthetic formulation. The NDA was filed Ju...
Akorn gains FDA vaccine approval
Akorn Inc. announced FDA approval of a supplemental biologics license application for a unit dose, preservative free tetanus diphtheria vaccine. Akorn...
Akorn says FDA approves Akten eye anesthetic
Eye care products maker Akorn Inc. said Wednesday that federal regulators approved its topical eye anesthetic Akten. Akorn said the Food and Drug Admi...
Akorn's generic antibiotic approved by FDA
Akorn Inc. said Wednesday it received Food and Drug Administration approval for a generic version of vancomycin, an antibiotic used against life-threa...
Alara Receives FDA Clearance For CRystalView T-Series CR System
Alara is showcasing the CRystalView T-Series desktop CR system at RSNA 2007 in Chicago. Alara, Inc. has received US Food and Drug Administration clear...
Alcon shelves study for eye drug Retaane for wet AMD after FDA approvable letter
Alcon said the US Food and Drug Administration has issued an approvable letter for its eye drug Retaane for the treatment of wet age-related retinal d...
All Eyes on FDA for Drug E-Pedigree
With the deadline for California's electronic-pedigree (e-pedigree) requirement for pharmaceuticals moved from Jan. 1, 2009, to Jan. 1, 2011, the push...
Allos lymphoma drug data Questioned by FDA staff
The findings from biotech company Allos Therapeutics Inc (ALTH.O) are questioned by U.S. drug reviewers on the effectiveness of its proposed drug for ...
Allow FDA to regulate cigarettes
After a troubling spell of stagnation, youth smoking rates have resumed their decline. In their 2007 Monitoring the Future Survey, researchers at the ... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2010 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |